Authors
Oscar B. Lahoud, MD, is clinical associate professor at NYU School of Medicine; section chief, Hematology, NYU Langone Health in Brooklyn; and director for strategy and network operations, Hematology/Oncology, the Perlmutter Cancer Center.
Neal Bhatia, MD
Director of Clinical Dermatology
Therapeutics Clinical Research
San Diego, CA
Sam Peasah, PhD, MBA, RPh, director of high-value health care, University of Pittsburgh Medical Center
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke
2
Pharmacy, Claims Data Show High Resmetirom Persistence in MASH
3
FDA Approves First Dual-Targeted Therapy for Advanced HNSCC
4
Survodutide Meets CV Safety End Point in SYNCHRONIZE-CVOT
5

